Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

Autor: Lefort, M.1,2 (AUTHOR), Sharmin, S.3,4 (AUTHOR), Andersen, J. B.5 (AUTHOR), Vukusic, S.6,7,8 (AUTHOR), Casey, R.6,7,8,9 (AUTHOR), Debouverie, M.10 (AUTHOR), Edan, G.11 (AUTHOR), Ciron, J.12 (AUTHOR), Ruet, A.13 (AUTHOR), De Sèze, J.14 (AUTHOR), Maillart, E.15 (AUTHOR), Zephir, H.16 (AUTHOR), Labauge, P.17 (AUTHOR), Defer, G.18 (AUTHOR), Lebrun-Frenay, C.19 (AUTHOR), Moreau, T.20 (AUTHOR), Berger, E.21 (AUTHOR), Clavelou, P.22 (AUTHOR), Pelletier, J.23 (AUTHOR), Stankoff, B.24 (AUTHOR)
Zdroj: BMC Medical Research Methodology. 5/30/2022, Vol. 22 Issue 1, p1-14. 14p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje